CorrlensCorrlens
Correlate

Correlation Analysis

IQVIA Holdings Inc. vs Eli Lilly & Co.

IQV vs LLY

-0.358

Light inverse

When one moves up, the other tends to move down.

IQV logo

IQVIA Holdings Inc.

IQV

Iqvia is a global leader in clinical research and technology solutions for the life science industry. Formed in 2016 from the merger of Quintiles and IMS Health, it combined clinical trial services with extensive healthcare data and analytics. Its reserach and development solutions segment provides outsourced clinical development services spanning drug discovery, trial design, patient recruitment, site management, clinical testing, real-world studies, and the regulatory approval process. Its commercial solutions segment helps companies optimize product commercialization through analytics, technology, and outsourced sales and medical services. Together, Iqvia supports customers across the life science industry, and it serves biopharmaceutical firms, providers, payers, and policymakers.

Market cap 28.7B · 93,000 employees

LLY logo

Eli Lilly & Co.

LLY

Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.

Market cap 828.2B · 50,000 employees

Apr 9, 2021 — Apr 7, 2026Daily1,254 data pointsStockStockHealthcare

Time Series

Relative Performance

Green: IQVGray: LLY36 of 1,254 points (sampled)

Who Moves First

LLY leads IQV by 6 days

LLY tends to move before IQV.

After testing 13 timing shifts, the strongest relationship was -0.369 (they moved in opposite directions).

Do They Crash Together?

Correlation by Market Regime

How these series behave when markets are rising, falling, or diverging. A correlation that holds in drawdowns is very different from one that only works in rallies.

Both Rising

-0.453

15 periods · Return correlation when both series rose

Both Falling

+0.075

7 periods · Return correlation when both series fell

Diverging

-0.275

13 periods · Return correlation when series moved apart

R-Squared

12.8%

Share of variance in one series explained by the other.

Trend Agreement

61.0%

How often both series moved in the same direction period-to-period.

Overlap Quality

1,254

Deep shared window — 1,254 usable pairs.

Significance

p < 0.001

95% CI: [-0.406, -0.309]

Scatter

XY Regression

127.7140160180200220240260280287.81142004006008001,0001,142IQVIA Holdings Inc.Eli Lilly & Co.Data pointsFit (r = -0.358)

Pipeline

Data quality details

Pipeline Summary

1,254 paired data points survived the daily window.

Raw input

1,254

1,254

Normalized

1,254

1,254

Prepared

1,254

1,254

Aligned

1,254

1,254

Invalid removed

0

A: 0 / B: 0

Duplicates removed

0

A: 0 / B: 0

Alignment drops

0

A: 0 / B: 0

Series A

IQV logo

IQVIA Holdings Inc.

IQV

Market cap 28.7B · 93,000 employees

Stock · 1,254 raw → 1,254 prepared

Series B

LLY logo

Eli Lilly & Co.

LLY

Market cap 828.2B · 50,000 employees

Stock · 1,254 raw → 1,254 prepared

Sign agreement

100.0%

How often both values share the same sign.

Zero crossings

5

Estimated crossover points between normalized spreads.

Slope

-3.4689

Linear regression slope.

Intercept

1315.7954

Linear regression intercept.

Related Extremes

Highest and Lowest Correlated

Saved 7 hours ago · ID: stock-iqv-vs-stock-lly-daily